Life Science & Biotech

Bioanalytical taps accountant for turnaround

July 9, 2012
J.K. Wall
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
More

Life sciences hold up in recession

June 25, 2012
J.K. Wall
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
More

Biomet gives ortho industry hope

June 18, 2012
J.K. Wall
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
More

Orthopedic startups attracting big moneyRestricted Content

June 9, 2012
J.K. Wall
The Warsaw area is well-known as the home of gigantic orthopedic implant companies and their suppliers. But now a handful of startups have been able to raise nearly $25 million in equity investments despite the recession—putting a bit more fuel into a fairly stagnant entrepreneurial sector.
More

House swipes at health law with repeal of medical device tax

June 8, 2012
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the 2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
More

IU research leads to new genetic test

June 4, 2012
J.K. Wall

It took the identification of 19 different genes for researchers at the Indiana University School of Medicine to develop a test for a rare form of cancer. But their gene-hunting has paid off, as a Texas-based company announced Monday the test is available for doctors to use.

More

U.S. losing drug-research jobs to other countries

May 17, 2012
Bloomberg News
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
More

Indiana slips in life sciences funding

May 14, 2012
J.K. Wall
Indiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies, according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More

Cancer tools help Roche with Alzheimer's drug

May 13, 2012
Bloomberg News
Treatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs that attack the same protein as Roche’s experimental drug.
More

SCHREIBER: Innovation will drive health care industryRestricted Content

May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More

BioCrossroads launches second seed fund

April 30, 2012
J.K. Wall
BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow to the point where they can attract venture capital or a corporate funder.
More

Zimmer profit up slightly, meets expectations

April 26, 2012
Associated Press
Indiana-based orthopedic implant maker Zimmer Holdings Inc. on Thursday reported a fractional increase in first-quarter profit on higher sales in all global regions, particularly the Asia Pacific.
More

Dow Agro sales surge on healthy ag market

April 26, 2012
J.K. Wall
Sales at Indianapolis-based Dow AgroSciences grew 14 percent in the first quarter, to $1.8 billion, helped by an early planting season in North America and a buoyant agricultural market.
More

Purdue set to start building life sciences park

April 19, 2012
Associated Press
The $38 million Lyles-Porter Hall will house numerous health programs. Purdue also is planning a $25 million Drug Discovery Building that will bring together pharmaceutical researchers from throughout the school.
More

Cook Group acquires local biotech company

April 9, 2012
 IBJ Staff
Bloomington-based medical device maker Cook Group has acquired General BioTechnology LLC, an Indianapolis biotech company with about 20 employees, Cook Group announced Monday.
More

New Lilly drug has small sales potential

April 9, 2012
J.K. Wall
Eli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
More

Biomet offers to acquire DePuy trauma biz for $280M

April 3, 2012
 IBJ Staff and Bloomberg News
Warsaw-based Biomet, which designs and manufactures orthopedic products for surgical and non-surgical uses, said the deal would greatly expand its sports, extremities and trauma business.
More

Roche's downsizing to claim about 80 local IT workers

March 29, 2012
 IBJ Staff
Roche Diagnostics Corp. plans to eliminate about 80 information technology jobs at its Indianapolis-area campus over the next two years, the company said Thursday morning.
More

Device maker Biomet paying $22.7M to settle bribery case

March 26, 2012
Associated Press
Indiana-based Biomet Inc. has agreed to pay $22.7 million to settle U.S. criminal and civil allegations that it bribed government-employed doctors in Argentina, Brazil and China for eight years to win business with hospitals.
More

Q&A

March 26, 2012
J.K. Wall
Tino Pereira, CEO of Canada-based Iotron Industries, discussed the electron-beam facility his company opened March 15 in Columbia City, which lies halfway between Fort Wayne and Warsaw in northern Indiana. Iotron already helps some of the orthopedic implant makers in Warsaw alter the strength, flexibility or surface conditions of the materials in the joint replacements they make. That makes its services important in research and development for new products.
More

Lilly receives Europe's OK for new Byetta use

March 23, 2012
 IBJ Staff and Associated Press, Associated Press
European regulators have approved an expanded use for the diabetes treatment Byetta, developed by Eli Lilly and Co. and Amylin Pharmaceuticals Inc. The FDA approved the same expanded use last fall.
More

Life sciences firm plans to expand, add 46 jobs

March 15, 2012
Noblesville-based Helmer Inc. said it will invest $10.6 million to build a new manufacturing and headquarters facility at the Saxony Corporate Campus near Interstate 69. It plans to add the jobs by 2014.
More

Endocyte pulls trigger on European drug submission

March 13, 2012
J.K. Wall
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after the European Commission granted it orphan drug status.
More

AIT Labs exec succeeding founder Evans as CEO

March 2, 2012
 IBJ Staff
The promotions of several executives follow the Indianapolis-based clinical testing company's announcement in January that it was cutting jobs and restructuring its business.
More

CityWay designed to integrate retail, housing, hotel, YMCARestricted Content

February 25, 2012
Marc D. Allan
Architects were told to push the envelope and integrate. Be mindful of where you are in the city and integrate well.
More
Page  << 1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT